GBM is characterized by abnormal activation of receptor tyrosine kinase signaling pathways, and constitutively activated STAT3 is frequently coexpressed with epidermal growth factor receptor (EGFR) in high-grade gliomas. This evidence concerns the gene EGFR and glioblastoma.